Product Article

Applied Filters:

facet content type:Product Article

facet product category:SMC® Technology

facet topic area:Cosmetics Personal Health

facet topic area:Drug Development

facet topic area:Immunology Inflammation

facet topic area:Neuroscience Research

facet topic area:Toxicity

Showing 1-9 of 9 results

Early Detection of Cardiotoxicity Biomarkers | SMC^® Technology

Cardiotoxicity biomarkers like cardiac troponin I (cTnI) in serum samples can be detected earlier with the ultrasensitive biomarker detection SMC® immunoassay platform. Discover the utility of Single Molecule Counting (SMC®) technology for the early assessment of heart muscle injury in

High-Sensitivity Immunoassays in PK/PD | SMC^® Technology

Explore this review of high-sensitivity immunoassays in PK/PD studies to see different case studies showing how ultrasensitive immunoassay technology, such as SMC® technology, is used for PK/PD profiling.

How High Sensitivity Immunogenicity Assays Overcome ADA Detection Challenges

How High Sensitivity Immunogenicity Assays Overcome the Challenges of Anti-Drug Antibody (ADA) Detection

How High Sensitivity Immunoassays Expand Neuroscience Research | SMC^® Technology

Discover how to expand neuroscience biomarker research with high sensitivity immunoassays, such as Single Molecule Counting (SMC®) assays. These assays give researchers the tools they need to detect low-abundant blood-based biomarkers and expand biomarker options in neuroscience research.

Power of High Sensitivity Immunology Assays| SMC^® Technology

Use the power of high sensitivity immunology assays with SMC® technology to precisely characterize low-abundant cytokines like those from Th1/Th2 and Th17 cells.

阿尔茨海默病生物标记物多重和高灵敏度免疫测定

了解如何结合MILLIPLEX®多重和单分子计数(SMC®)高灵敏度蛋白免疫测定技术，检测人脑脊液、血浆和血清样本中的阿尔茨海默病(AD)生物标志物，开展神经科学深度研究。

Integrating Multiplex and High Sensitivity Immunoassay Detection of Alzheimer’s Disease Biomarkers

Learn how to integrate multiplex and high sensitivity immunoassay technology to further neuroscience research with MILLIPLEX® multiplex and Single Molecule Counting (SMC®) high sensitivity immunoassay detection of Alzheimer’s disease (AD) biomarkers in human cerebrospinal fluid, plasma, and serum samples.

Drug Development Research | SMC^® Technology

Learn how ultrasensitive biomarker detection platforms, such as the SMC® technology platform, can enable the acceleration of drug development research programs through enhanced PK/PD and immunogenicity testing.

Immunoassays for Cosmetics and Personal Care Research

Learn how immunoassays are used in cosmetics and personal care research to discover potential harmful effects of cosmetics products, and assess markers of inflammation, sensitization, aging, and tissue regeneration among others.